HIGHLAND CAPITAL MANAGEMENT LP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 118 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.85 and the average weighting 0.5%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$4,605,000
-64.5%
1,153,993
-52.3%
0.27%
-66.7%
Q1 2019$12,955,000
+5.6%
2,416,993
+1.0%
0.81%
-14.2%
Q4 2018$12,271,000
-52.3%
2,391,993
-9.9%
0.94%
-33.8%
Q3 2018$25,748,000
+31.6%
2,654,428
+38.4%
1.42%
+27.9%
Q2 2018$19,562,000
+56.9%
1,917,878
+99.9%
1.11%
+72.8%
Q1 2018$12,471,000
+205.7%
959,278
+320.9%
0.64%
+243.9%
Q4 2017$4,079,000
+237.9%
227,900
+373.8%
0.19%
+252.8%
Q3 2017$1,207,000
+109.2%
48,100
+60.3%
0.05%
+82.8%
Q1 2017$577,000
-44.7%
30,000
-60.0%
0.03%
-32.6%
Q2 2016$1,044,00075,0000.04%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders